Caffeic acid-pYEEIE (TFA)

Caffeic acid-pYEEIE (TFA)

• UNSPSC Description: Caffeic acid-pYEEIE TFA, a non-phosphopeptide inhibitor, exhibits potent binding affinity for the GST-Lck-SH2 domain[1].
• Target Antigen: Src
• Type: Peptides
• Related Pathways: Protein Tyrosine Kinase/RTK
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/caffeic-acid-pyeeie-tfa.html
• Purity: 98.47
• Solubility: H2O : 25 mg/mL (ultrasonic)
• Smiles: O=C(O)CC[C@@H](C(O)=O)NC([C@H]([C@@H](C)CC)NC([C@H](CCC(O)=O)NC([C@H](CCC(O)=O)NC([C@H](CC1=CC=C(OP(O)(O)=O)C=C1)NC(/C=C/C2=CC=C(O)C(O)=C2)=O)=O)=O)=O)=O.OC(C(F)(F)F)=O
• Molecular Weight: 1037.83
• References & Citations: [1]See-Hyoung Park, et al. Design and characterization of non-phosphopeptide inhibitors for Src family SH2 domains. Bioorg Med Chem Lett. 2002 Oct 7;12(19):2711-4.
• Shipping Conditions: Blue Ice
• Storage Conditions: -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
• Clinical Information: No Development Reported